Results 1 to 10 of about 36,803 (257)
Closed‐Loop Bioelectronic Artificial Pancreas Patch for Continuous Monitoring and Regulation of Blood Glucose in Diabetic Rats and Pigs [PDF]
Advanced ScienceIntegrated artificial pancreas devices with continuous glucose monitoring (CGM) and closed‐loop insulin delivery are crucial for diabetes management.
Yiqun Liu +9 more
doaj +2 more sources
A Deep Learning Framework for Automatic Meal Detection and Estimation in Artificial Pancreas Systems
Sensors, 2022 Current artificial pancreas (AP) systems are hybrid closed-loop systems that require manual meal announcements to manage postprandial glucose control effectively. This poses a cognitive burden and challenge to users with T1D since this relies on frequent
John Daniels +2 more
doaj +1 more source
Diabetology & Metabolic Syndrome, 2022 Background The purpose of this study was to assess the effectiveness and safety of a model predictive control (MPC) algorithm for an artificial pancreas system in outpatients with type 1 diabetes. Methods We searched PubMed, EMBASE, Cochrane Central, and
Su Lim Kang +3 more
doaj +1 more source
Current Opinion in Organ Transplantation, 2020 Purpose of review Advances in diabetes technologies have enabled the development of artificial pancreas (closed-loop) systems for people with diabetes. We review the key studies which have led to the adoption of the artificial pancreas in clinical practice and consider ongoing challenges and areas for future enhancements.
Boughton, Charlotte, Hovorka, Roman
openaire +3 more sources
An implantable artificial pancreas [PDF]
Medical & Biological Engineering & Computing, 1980 The artificial implantable pancreas is seen as the optimal means of therapy in patients with severe diabetes mellitus. The implantable pancreas consists of three modules; (i) the dosing unit, (ii) the control circuit and (iii) a glucose sensor for the realisation of a feedback system.
Schubert, Wolfgang +4 more
openaire +3 more sources
Frontiers in Pediatrics, 2021 The goal in type 1 diabetes (T1D) therapy is to maintain optimal glycemic control under any circumstance. Diabetes technology is in continuous development to achieve this goal. The most advanced Food and Drug Administration- and European Medicines Agency-
Jesus Dominguez-Riscart +9 more
doaj +1 more source
Pancreas transplantation with isolated splenic artery blood supply – Single center experience
Asian Journal of Surgery, 2020 Summary: Background: The blood supply of the native pancreas by three arterial lines from the celiac trunk system (splenic artery and common hepatic artery) and the superior mesenteric artery forces surgeons to perform vascular reconstruction to provide
Alexey V. Pinchuk +7 more
doaj +1 more source
Dynamic Insulin Basal Needs Estimation and Parameters Adjustment in Type 1 Diabetes
Sensors, 2021 Technology advances have made possible improvements such as Continuous Glucose Monitors, giving the patient a glucose reading every few minutes, or insulin pumps, allowing more personalized therapies.
Jesús Berián +4 more
doaj +1 more source
Impact of using a perioperative artificial endocrine pancreas in pancreatic resection
Annals of Gastroenterological Surgery, 2020 Aim Pancreatectomy causes both hyperglycemia, secondary to surgical stress, and pancreatic diabetes, which leads to difficult‐to‐control postoperative blood glucose levels.
Toshiaki Yoshimoto +8 more
doaj +1 more source
Evaluation of Offline Reinforcement Learning for Blood Glucose Level Control in Type 1 Diabetes
IEEE Access, 2023 Patients with Type 1 diabetes must closely monitor their blood glucose levels and inject insulin to control them. Automated glucose control methods that remove the need for human intervention have been proposed, and reinforcement learning has been used ...
Phuwadol Viroonluecha +2 more
doaj +1 more source